Shuang Liu, Chunmei Xiao, Yue Rong, Mingbo Liu, Ke Yang, Jing Tang, Zhigang Wang: Comprehensive analysis of ferroptosis-related genes indicates that TRIM46 is a novel biomarker and promotes the progression of ovarian cancer via modulating ferroptosis and Wnt signaling pathway. Am J Cancer Res 2024;14(10):4686-4707. (Full text, PDF)
Bingxin Yu, Xingsheng Zuo, Chenglong Zhao: Efficacy of abiraterone combined with prednisone in castration-resistant prostate cancer and its impact on miR-221/222 expression. Am J Cancer Res 2024;14(10):4708-4716. (Full text, PDF)
Wei-Lun Huang, Sih-Han Chen, Richard Chen-Yu Wu, Hsing-Cha Mai, Chun-Hsien Wu, Pei-Fang Hsieh, See-Tong Pang, Victor Chia-Hsiang Lin: Knockdown of EPS8 expression attenuates the proliferation of enzalutamide-resistant prostate cancer cells. Am J Cancer Res 2024;14(10):4717-4730. (Full text, PDF)
Xu Liu, Jin Yuan, Xinfeng Wang, Shengji Yu: Development and validation of a machine learning-based model to predict postoperative overall survival in patients with soft tissue sarcoma: a retrospective cohort study. Am J Cancer Res 2024;14(10):4731-4746. (Full text, PDF)
Chiao-Yun Lin, Chen-Yang Huang, Cheng-Chi Lee, Lien-Min Li, Ya-Fang Lee, Shi-Ming Jung, Hsien-Chi Fan, An-Chi Lin, Cheng-Lung Hsu, Yin-Cheng Huang: A patient-derived xenograft mouse platform from epithelioid glioblastoma provides possible druggable screening and translational study. Am J Cancer Res 2024;14(10):4747-4759. (Full text, PDF)
Ming-Jie Gong, Zhi-Gang Lai, Yun-Xia Zhang, Na Hu: Risk factor analysis and development of predictive models for osteoradionecrosis in patients with nasopharyngeal carcinoma after concurrent chemoradiotherapy. Am J Cancer Res 2024;14(10):4760-4771. (Full text, PDF)
Sirinapa Szewczyk, Brian Buckley, Mikhail Chernov, Xinjiang Wang, Shilpa Pathak, Herman Yeger, Kristopher M Attwood, Renae Holtz, Christine B Ambrosone, Michael J Higgins: Cell-based assay to detect small molecules restoring levels of let-7 miRNAs. Am J Cancer Res 2024;14(10):4772-4787. (Full text, PDF)
Patrick J Stiff, Elizabeth Kertowidjojo, Ronald K Potkul, Swarnali Banerjee, Swati Mehrotra, William Small Jr, M Sharon Stack, Maureen L Drakes: Cabozantinib inhibits tumor growth in mice with ovarian cancer. Am J Cancer Res 2024;14(10):4788-4802. (Full text, PDF)
Lei Chen, Cong Xu, Weihao Ren, Lei Yu, Tian Tang: Predicting immunotherapy-related adverse events in late-stage non-small cell lung cancer with KARS G12C mutation treated with PD-1 inhibitors through combined assessment of LCP1 and ADPGK expression levels. Am J Cancer Res 2024;14(10):4803-4816. (Full text, PDF)
Hung-Hsing Chiang, Kuan-Li Wu, Hung-Pei Tsai, Chai-Tung Ong, Chao-Yuan Chang, Yu-Yuan Wu, Tzu-Yen Shen, Jen-Yu Hung, Hsiao-Chen Lee, Ya-Ling Hsu, Ying-Ming Tsai: Comprehensive analysis of the oncogenic potential of eukaryotic initiation factor 3M via SAAL1 interaction in lung adenocarcinoma. Am J Cancer Res 2024;14(10):4817-4829. (Full text, PDF)
Chunyu Wang, Hongwen Cao, Peng Sun, Lei Chen, Yigeng Feng, Renjie Gao: NRG1 secreted by cancer-associated fibroblasts contributes to enzalutamide resistance in prostate cancer cells. Am J Cancer Res 2024;14(10):4830-4840. (Full text, PDF)
Yanrong Liu, Ziyan Zhang, Jianzhong Huo: Construction and clinical validation of risk model for predicting bone cement leakage after the surgical management of spinal metastases. Am J Cancer Res 2024;14(10):4841-4854. (Full text, PDF)
Ya-Yun Wang, Jing Zhang, Xiong Zhuang, Qiu-Yan Jin, Liang-Qing Liu: Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MRI improves diagnosis and efficacy evaluation of early-stage hepatocellular carcinoma. Am J Cancer Res 2024;14(10):4855-4867. (Full text, PDF)
Fang Cheng, Xijia Ma, Zhenyang Cheng, Yami Wang, Xuelin Zhang, Chunzheng Ma: Predict value of tumor markers combined with interleukins for therapeutic efficacy and prognosis in ovarian cancer patients. Am J Cancer Res 2024;14(10):4868-4879. (Full text, PDF)
Xinyi Guo, Ronglan Wen, Liangfei Yu, Hui Lin: Tumor size, HER-2 status, CA125, CEA, SII, and PNI: key predictors of pathological complete response in LABC patients. Am J Cancer Res 2024;14(10):4880-4895. (Full text, PDF)
Ke Yang, Fangmiao Gao, Chenxuan Zhou, Sinan Cao, Shuaining Chai, Linwei Li: Immunological biomarkers and predictive model for recurrence of esophageal squamous cell carcinoma after combined immunotherapy and neoadjuvant chemotherapy. Am J Cancer Res 2024;14(10):4896-4908. (Full text, PDF)
Min Wang, Jianrong Wen, Peijun Liu: Identification of high-risk tumor characteristics in patients with localized prostate cancer using conventional combined with diffusion-weighted MRI imaging parameters. Am J Cancer Res 2024;14(10):4909-4921. (Full text, PDF)
Rongce Zhao, Jing Zhou, Xinhao Xiong, Qiaoxuan Wang, Chunxiao Liu, Wei Wei, Shaohua Li, Rongping Guo: Hepatic arterial infusion chemotherapy in combination with lenvatinib and durvalumab versus standard first-line treatment gemcitabine and cisplatin plus durvalumab in advanced intrahepatic cholangiocarcinoma. Am J Cancer Res 2024;14(10):4922-4934. (Full text, PDF)
Chuang Li, Weihong Dong, Yawei Li: Diagnosis and differentiation of Kaposiform hemangioendothelioma based on ultrasound radiomics. Am J Cancer Res 2024;14(10):4935-4945. (Full text, PDF)
Jin Jiang, Tingxiao Zhao, Longtao Yao, Tao Zhang, Lichen Ji, Wei Zhang, Yanlei Li, Jinlong Tian, Xiaoyan Ding, Yongqin Lin, Liang Han: Preoperative prognostic nutritional index and systemic immune inflammation index for predicting the efficacy and survival time of patients with osteosarcoma undergoing neoadjuvant chemotherapy combined with surgery. Am J Cancer Res 2024;14(10):4946-4955. (Full text, PDF)
Hsuan-Yi Huang, Chia-Jen Tsai, Chia-Lin Chou, Li-Chin Cheng, Yu-Hsuan Kuo, Yu-Cih Wu, Chung-Han Ho, Ching-Chieh Yang: Survival benefit of surgery in elderly patients with locally advanced rectal cancer. Am J Cancer Res 2024;14(10):4956-4968. (Full text, PDF)
Shulian Chen, Xiaoyu Zhang, Ting Niu, Yajing Xu, Guangxun Gao, Shengjin Fan, Zeping Zhou, Fang Zhou, Fei Li, Li Liu, Wei Yang, Qifa Liu, Xi Zhang, Yi He, Sizhou Feng, Mingzhe Han, Weihua Zhai, Erlie Jiang: The modified melphalan and busulfan-based regimen combined with maintenance therapy improved the survival of patients with refractory/relapsed AML after allogeneic transplantation: middle-term outcome of a multicenter trial. Am J Cancer Res 2024;14(10):4969-4978. (Full text, PDF)
Yuan-Sheng Chang, Mu-Jung Tsai, Chieh-Jui Tsai, Chih-Chi Wang, Chih-Che Lin, Yi-Hao Yen, Chao-Hung Hung, Yuan-Hung Kuo, Ding-Sen Huang, Wei-Chen Tai, Tsung-Hui Hu, Ming-Chao Tsai: A new model based on preoperative AFP, albumin, and tumor burden score for predicting microvascular invasion in early-stage HCC. Am J Cancer Res 2024;14(10):4979-4988. (Full text, PDF)
Hui-I Yu, Hong-Yi Chang, Chieh-Hsiang Lu, Tsai-Sung Tai, Fang-Ping Kung, Yi-Sheng Zhang, Yi-Ping Chang, Yi-Zhen Li, Shu-Hsin Chen, Jhy-Shrian Huang, Ying-Ray Lee: Evodiamine exerts anti-cancer activity including growth inhibition, cell cycle arrest, and apoptosis induction in human follicular thyroid cancers. Am J Cancer Res 2024;14(10):4989-4999. (Full text, PDF)
Li Zhou, Jian Yang, Shubei Wang, Pin Guo, Keman Liao, Zhonggang Shi, Jianyi Zhao, Shukai Lin, Ming Yang, Gang Cai, Qing Xia, Jianwei Ge, Jiayi Chen, Yingying Lin: Generation and banking of patient-derived glioblastoma organoid and its application in cancer neuroscience. Am J Cancer Res 2024;14(10):5000-5010. (Full text, PDF)